Clinical Trial Update: Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating concurrent nab-paclitaxel and carboplatin with thoracic radiotherapy in squamous cell non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell | Phase 2 | Status: UNKNOWN